BACKGROUND: A missense mutation of the THAP1 gene results in DYT6 primary dystonia. While deep brain stimulation (DBS) of the internal globus pallidus (GPi) is effective in treating primary dystonia, recent reports indicate that GPi DBS is only mildly effective for DYT6 dystonia. OBJECTIVE: To describe a patient with DYT6 dystonia who underwent thalamic ventral lateral anterior (VLa) nucleus DBS. PATIENT: A 35-year-old Japanese man had been experiencing upper limb dystonia and spasmodic dysphonia since the age of 15. His dystonic symptoms progressed to generalized dystonia. He was diagnosed as having DYT6 dystonia with mutations in the THAP1 gene. Because his dystonic symptoms were refractory to pharmacotherapy and pallidal DBS, he underwent thalamic VLa DBS. RESULTS: Continuous bilateral VLa stimulation with optimal parameter settings ameliorated the patient's dystonic symptoms. At the 2-year follow-up, his Burke-Fahn-Marsden Dystonia Rating Scale total score decreased from 71 to 11, an improvement of more than 80%. CONCLUSIONS: The thalamic VLa nucleus could serve as an alternative target in DBS therapy for DYT6 dystonia.
BACKGROUND: A missense mutation of the THAP1 gene results in DYT6primary dystonia. While deep brain stimulation (DBS) of the internal globus pallidus (GPi) is effective in treating primary dystonia, recent reports indicate that GPi DBS is only mildly effective for DYT6dystonia. OBJECTIVE: To describe a patient with DYT6dystonia who underwent thalamic ventral lateral anterior (VLa) nucleus DBS. PATIENT: A 35-year-old Japanese man had been experiencing upper limb dystonia and spasmodic dysphonia since the age of 15. His dystonic symptoms progressed to generalized dystonia. He was diagnosed as having DYT6dystonia with mutations in the THAP1 gene. Because his dystonic symptoms were refractory to pharmacotherapy and pallidal DBS, he underwent thalamic VLa DBS. RESULTS: Continuous bilateral VLa stimulation with optimal parameter settings ameliorated the patient's dystonic symptoms. At the 2-year follow-up, his Burke-Fahn-Marsden Dystonia Rating Scale total score decreased from 71 to 11, an improvement of more than 80%. CONCLUSIONS: The thalamic VLa nucleus could serve as an alternative target in DBS therapy for DYT6dystonia.
Authors: Vikram G Shakkottai; Amit Batla; Kailash Bhatia; William T Dauer; Christian Dresel; Martin Niethammer; David Eidelberg; Robert S Raike; Yoland Smith; H A Jinnah; Ellen J Hess; Sabine Meunier; Mark Hallett; Rachel Fremont; Kamran Khodakhah; Mark S LeDoux; Traian Popa; Cécile Gallea; Stéphane Lehericy; Andreea C Bostan; Peter L Strick Journal: Cerebellum Date: 2017-04 Impact factor: 3.847
Authors: H A Jinnah; Ron Alterman; Christine Klein; Joachim K Krauss; Elena Moro; Marie Vidailhet; Robert Raike Journal: J Neural Transm (Vienna) Date: 2017-02-03 Impact factor: 3.575
Authors: Mary E Finger; Mustafa S Siddiqui; Amy K Morris; Kathryn W Ruckart; S Carter Wright; Ihtsham U Haq; Lyndsay L Madden Journal: J Voice Date: 2019-03-14 Impact factor: 2.009
Authors: Virgilio Gerald H Evidente; Francisco A Ponce; Maris H Evidente; Margaret Lambert; Robin Garrett; Manikandan Sugumaran; David G Lott Journal: Tremor Other Hyperkinet Mov (N Y) Date: 2020-12-31
Authors: Robert L Owen; Sanjeet S Grewal; Jessica M Thompson; Anhar Hassan; Kendall H Lee; Bryan T Klassen Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2022-02-21